FDA Finds Another Wockhardt Facility Out of Compliance

Morton Grove Pharmaceuticals, a subsidiary of Wockhardt, received a warning letter from the FDA listing GMP compliance issues at its Illinois facility, including insufficient investigations into product instability.
Source: Drug Industry Daily